Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Changes
Sattva Sukun Lifecare Ltd 路 Outcome 路 08 Sept 2026, 12:50 am
Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Changes Tavexia Lifecare's board approved evaluating an acquisition of up to 60% equity in unlisted Meyonex Pharmaceuticals (paid-up capital: Rs 13.99 crore), authorizing directors to conduct due diligence, valuation, and negotiations. The board accepted the resignation of statutory auditor M/s SSRV & Associates effective 7th Sep'26 and approved the appointment of M/s DEVAM & Associates LLP for a five-year term (FY27 to FY31), subject to shareholder approval. Additionally, the board re-appointed Khushboo Vasudev as Independent Director for five years from 31st Dec'26 and scheduled the 46th AGM.
Original exchange filing (PDF)
More announcements from Sattva Sukun Lifecare Ltd
- Financial Result 路 05 Nov 2026
- Announcement 路 05 Nov 2026
- Board has Approved in Change in RTA 路 05 Nov 2026
- Result 路 05 Nov 2026
- Outcome of Board Meeting 路 05 Nov 2026
- Tavexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting 路 04 Nov 2026
- Announcement 路 13 Oct 2026
- Disclosure under regulation 30 路 12 Oct 2026
